Meng Xi,Sun Hongfu,Huang Wei.Progress in the application of PD-(L)1 PET-targeted nuclide probes for tumor immunotherapy-related studies[J].Chinese Journal of Radiological Medicine and Protection,2024,44(2):158-162
Progress in the application of PD-(L)1 PET-targeted nuclide probes for tumor immunotherapy-related studies
Received:July 03, 2023  
DOI:10.3760/cma.j.cn112271-20230703-00223
KeyWords:programmed death receptor-1/programmed death receptor-ligand 1  Molecular imaging  Positron emission computed tomography tracer  Immunotherapy
FundProject:
Author NameAffiliationE-mail
Meng Xi Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China  
Sun Hongfu Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China  
Huang Wei Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China alvinbird@163.com 
Hits: 512
Download times: 150
Abstract::
      Immunotherapy has entered the clinical treatment for various tumors, among which the blockade therapy of PD-1/PD-L1 immune checkpoint is currently the most important tumor immunotherapy method. At present, immunohistochemical method are used in clinical practice to detect PD-L1 expression in tumor patients and screen for indications. However, this method is constrained by factors such as heterogeneity, dynamic changes in PD-L1 expression, and limited sample collection. PD-(L)1 PET imaging utilizes radiolabeled molecules to non-invasively assess PD-(L)1 expression in space and time, and complementary use with IHC has theoretically incomparable advantages. This article reviews the latest progress in the PD-(L)1 probe molecular imaging principles, clinical research and existing problems.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:9061372  On-line:0

v
Scan QR Code
&et=36358E19F9C507AE40294F9FC92ED085F2D28B05CD23EBC50BA0E69557D47E7B651590A32852DB37F8CAA682C8508C9A2D4CD47E1BE8607A01DC070B357C97F9A52D8C51FB89E758002E9349E37FA60C07B15C38D4F0B27C809422375F0FA603A1EC010E3F133CD29BBE60272A9272F6&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=B80136CCD8DCBAA1&aid=&vid=&iid=0B39A22176CE99FB&sid=4C100B7696CE9E24&eid=F1177A9DF1349B63&fileno=20240212&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="B80136CCD8DCBAA1"; var my_aid="";